References
Feb 1, 1996·Nature Medicine·I B McInnesF Y Liew
Feb 1, 1997·Nature Medicine·I B McInnesF Y Liew
Mar 5, 1998·Clinical and Experimental Immunology·A M MalfaitM Feldmann
Apr 29, 1998·The Journal of Clinical Investigation·N Oppenheimer-MarksP E Lipsky
Sep 29, 1998·Arthritis and Rheumatism·F Wolfe, J T Sharp
Jun 16, 2001·Arthritis and Rheumatism·G S CheemaW Stohl
Mar 16, 2002·Nature Structural Biology·Christopher PargellisJohn Regan
Mar 29, 2002·Arthritis and Rheumatism·Stanley CohenDorothy McCabe
Nov 16, 2002·Immunity·Sigrid DuboisYutaka Tagaya
Apr 11, 2003·Arthritis and Rheumatism·Roy M FleischmannGordon Sun
May 15, 2003·Arthritis and Rheumatism·Peter K K WongIan P Wicks
May 16, 2003·Nature·Gary S Firestein
Jul 16, 2003·Annals of the Rheumatic Diseases·J J HaringmanP P Tak
Nov 14, 2003·The New England Journal of Medicine·Joel M KremerLarry W Moreland
Nov 18, 2003·The Journal of Clinical Investigation·Louise S VilladsenJan G J van de Winkel
Feb 12, 2004·Arthritis and Rheumatism·Philip N HawkinsMichael F McDermott
Mar 6, 2004·Lancet·Lars KlareskogUNKNOWN TEMPO (Trial of Etanercept and Methotrexate with Radiographic Patient Outcomes) study investigators
Mar 17, 2004·Annals of the Rheumatic Diseases·D O' GradaighJ E Compston
Mar 17, 2004·Arthritis and Rheumatism·Robert Landewé, Désirée van der Heijde
Apr 15, 2004·Annals of the Rheumatic Diseases·S B CohenUNKNOWN 990145 Study Group
May 18, 2004·Arthritis and Rheumatism·Mark C GenoveseUNKNOWN 20000223 Study Group
Jun 3, 2004·Rheumatic Diseases Clinics of North America·Ernest Choy
Jun 3, 2004·Rheumatic Diseases Clinics of North America·Charles A Dinarello
Jun 10, 2004·Arthritis and Rheumatism·Norihiro NishimotoTadamitsu Kishimoto
Jun 18, 2004·The New England Journal of Medicine·Jonathan C W EdwardsTim Shaw
Jun 23, 2004·Lancet·David W McCareyNaveed Sattar
Jul 13, 2004·Arthritis and Rheumatism·Steven R Goldring, Ellen M Gravallese
Sep 10, 2004·Current Rheumatology Reports·Iain B McInnes, J Alastair Gracie
Nov 6, 2004·Arthritis and Rheumatism·E William St ClairUNKNOWN Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset Study Grou
Nov 16, 2004·Lancet·Hal M HoffmanGary S Firestein
Dec 22, 2004·The Journal of Investigative Dermatology·Catharine L KauffmanMary Ann Mascelli
Jan 11, 2005·Arthritis and Rheumatism·Désirée van der HeijdeSaeed Fatenejad
Mar 26, 2005·Immunological Reviews·Jörg J Goronzy, Cornelia M Weyand
Jun 11, 2005·The New England Journal of Medicine·Annette Langer-GouldDaniel Pelletier
Jun 11, 2005·The New England Journal of Medicine·B K Kleinschmidt-DeMasters, Kenneth L Tyler
Jun 11, 2005·The New England Journal of Medicine·Joseph R Berger, Igor J Koralnik
Jul 30, 2005·Arthritis and Rheumatism·Joel M KremerLarry W Moreland
Sep 6, 2005·Arthritis and Rheumatism·Thomas A Waldmann
Sep 6, 2005·Arthritis and Rheumatism·Bo BaslundIain B McInnes
Sep 16, 2005·The New England Journal of Medicine·Mark C GenoveseMaxime Dougados
Mar 2, 2006·Arthritis and Rheumatism·Josef S SmolenUNKNOWN Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset (ASPIRE) S